Health Care/Hospital
First patient in treatment in RhoVac's clinical phase IIb study in United Kingdom
STOCKHOLM, Jan. 7, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, on January 7th, 2021, that the first patient in United Kingdom is enrolled in the company's clinical phase IIb study in prostate cancer, a study named RhoVac-002 ("BRaVac"). The first patient in United Kingdom is enroll...
2021-01-07 22:40
2170
Inteleos and APA Partner to Offer Free Mental Health Resources to All Healthcare Professionals
Participation includes complimentary AMA PRA Category 1 CME Credit™ ROCKVILLE, Maryland. and WASHINGTON, Jan. 7, 2021 /PRNewswire/ -- Inteleos, a non-profit global healthcare certification organization, and theAmerican Psychological Association (APA), the leading scientific and professional or...
2021-01-07 22:02
2142
Caprion-HistoGeneX Acquires Clinical Logistics Inc., a Virtual Central Specimen Management CRO, and Expands its Support of Clinical Trials Specimen Logistics
MONTREAL, Jan. 7, 2021 /PRNewswire/ -- Caprion-HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners, announced today the acquisition of Clinical Logistics Inc. ("CLI"), a Virtual Central Specimen Management CRO based inHalifax, Canada. The...
2021-01-07 21:20
2919
Medical Waste Management Inherits a Multi-billion Dollar Opportunity from the Ongoing Pandemic
Asia-Pacific presents immense growth opportunities for medical waste management market participants as regulations mature and are thoroughly enforced, says Frost & Sullivan SANTA CLARA, Calif., Jan. 7, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis,Growth Opportunities in the Medical Wa...
2021-01-07 21:10
2404
Dr David Stamler Appointed CEO
MELBOURNE, Australia, Jan. 7, 2021 /PRNewswire/ -- The Board of Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") is pleased to announce the appointment of DrDavid Stamler to the role of Chief Executive Office effective immediately. Dr Stamler joined the Company in J...
2021-01-07 21:00
12312
Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies
CAMBRIDGE, Mass. and SUZHOU, China, Jan. 7, 2021 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced the first closing of an oversubscribed$53.5 million Series B+ fina...
2021-01-07 20:31
2994
CORI Innolab Launches CORI Super Recharge 96(TM): Rechargeable Super Mask on Kickstarter
SINGAPORE, Jan. 7, 2021 /PRNewswire/ -- CORI Innolab (Formerly known as CORI Traveller), the makers ofCORI SuperMask™ and SuperMask™ Active, has launched an ultra-breathable, rechargeable high-performance mask that allows users to retain the mask filtration efficacy through triboelectric mechanis...
2021-01-07 20:00
1844
IACTA Pharmaceuticals and Pharmaleads to Develop the World's First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain
- Ocular Pain, a $10+ billion global market, with significant unmet medical need - License agreement aims to accelerate global development of DENKIs, leveraging expertise and resources of both companies IRVINE, California, PARIS, HONG KONG, Jan. 7, 2021 /PRNewswire/ -- IACTA Pharmaceuticals, Inc...
2021-01-07 20:00
2584
VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China
SHANGHAI, Jan. 7, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company committed to the treatment of endocrine-related diseases, introducing the world's leading treatment methods and drugs into theChina market and hoping to provide more Chinese patients quick access to the world's most a...
2021-01-07 18:45
1702
Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics
- Adds to Merck's lipid manufacturing expertise, providing an integrated offering across mRNA value chain - AmpTec's differentiated polymerase chain reaction (PCR)-based technology has shown to have advantages over other technologies for mRNA manufacturing - Diagnostics business focused on produ...
2021-01-07 17:00
4665
Qiming Venture Partners' Portfolio Company APT Medical Listed on STAR Board of Shanghai Stock Exchange
SHANGHAI, Jan. 7, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company APT Medical (SHSE: 688617) today successfully listed on the Science and Technology Innovation Board (the STAR Board) of Shanghai Stock Exchange. The issue price isCNY 74.46 per share. The stock opened at CNY 221.73 ...
2021-01-07 16:13
4259
GEN inCode Appoints New Chairman
OXFORD, England, Jan. 7, 2021 /PRNewswire/ -- GEN inCode UK Limitedthe privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, announces today the appointment of Bill Rhodes as non-executive Chairman of the Company, effective 1 Ja...
2021-01-07 15:00
5587
KAIST Mobile Clinic Module to Fill Negative Pressure Ward Shortage
DAEJEON, South Korea, Jan. 6, 2021 /PRNewswire/ -- A team from KAIST has developed a low-cost and ready-for-rapid-production negative pressure room called a Mobile Clinic Module (MCM). The MCM is expandable, moveable, and easy to store through a combination of negative pressure frames, air tents...
2021-01-07 12:00
2071
KAIST Mobile Clinic Module to Relieve Demand for Negative Pressure Beds
DAEJEON, South Korea, Jan. 6, 2021 /PRNewswire/ -- A KAIST team has developed a low-cost and ready-for-rapid-production negative pressure room called a Mobile Clinic Module (MCM). The MCM expects to quickly meet the high demand for negative pressure beds in the nation and eventually many other c...
2021-01-07 12:00
1825
New Thai health drink 'QminC' surges during COVID-19 pandemic
BANGKOK, Jan. 7, 2021 /PRNewswire/ -- Four months after its launch in Thailand , an innovative health drink fortified with curcumin extracted from the turmeric plant's rootstalks, has found its way on to the shelves of more than 15,000 modern trade retail outlets and almost 500,000 mom and pop s...
2021-01-07 11:31
10402
CGTN: What drives China's success in 2020
BEIJING, Jan. 6, 2021 /PRNewswire/ -- Facing unprecedented challenges brought by COVID-19 and the complex changes in external environment, the Communist Party ofChina (CPC) Central Committee with Comrade Xi Jinping at the core has ledChina to achieve substantial progress in 2020. &nb...
2021-01-06 23:16
4443
Bioworkshops successfully passed EU QP audit
SUZHOU, China, Jan. 6, 2021 /PRNewswire/ -- In November 2020, Bioworkshops passed a European drug Qualified Person audit (QP audit) for manufacture of clinical drug substance and drug product at their Suzhou site. The ratification of compliance to EU GMP comes within a month of obtaining a Drug M...
2021-01-06 22:00
1941
Everest Medicines Announces CTA Approval by China NMPA for Phase 3 Trial of Sacituzumab Govitecan-Hziy for Metastatic Urothelial Cancer
SHANGHAI, Jan. 6, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, today announced th...
2021-01-06 21:54
7030
Everest Medicines Initiates Submission of New Drug Application in Singapore for Sacituzumab Govitecan-Hziy for the Treatment of Metastatic Triple-Negative Breast Cancer
SHANGHAI, Jan. 6, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, announced today th...
2021-01-06 21:52
7123
VolitionRx Limited Awarded an Additional $4 Million in Non-Dilutive Funding
AUSTIN, Texas, Jan. 6, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it has been awarded additional non-dilutive funding totaling approximately$4 million from the Walloon Region and Namur Invest,Belgium. To date, Agencies from the Walloon Region have a...
2021-01-06 21:25
9805
Week's Top Stories
Most Reposted
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 278 media titles]
2025-12-26 12:55Vietnam's Newest EDM Destination, APLUS SAIGON, Debuts With Star-Studded Soft Opening Weekends Featuring Dombresky and Argy
[Picked up by 273 media titles]
2025-12-30 20:12
ACEN completes transition to 100% renewable energy
[Picked up by 273 media titles]
2025-12-29 18:53iQIYI LAND Yangzhou to Open on February 8, Marking New Chapter in China's Immersive Entertainment Scene
[Picked up by 269 media titles]
2026-01-01 10:00
CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 263 media titles]
2025-12-29 09:00
